NO955288L - Skvalen-syntetase inhibitorer - Google Patents
Skvalen-syntetase inhibitorerInfo
- Publication number
- NO955288L NO955288L NO955288A NO955288A NO955288L NO 955288 L NO955288 L NO 955288L NO 955288 A NO955288 A NO 955288A NO 955288 A NO955288 A NO 955288A NO 955288 L NO955288 L NO 955288L
- Authority
- NO
- Norway
- Prior art keywords
- synthetase inhibitors
- squalene synthetase
- agents
- squalene
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36271394A | 1994-12-23 | 1994-12-23 | |
PCT/IB1995/000424 WO1996020184A1 (en) | 1994-12-23 | 1995-06-02 | Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO955288D0 NO955288D0 (no) | 1995-12-22 |
NO955288L true NO955288L (no) | 1996-06-24 |
Family
ID=23427229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO955288A NO955288L (no) | 1994-12-23 | 1995-12-22 | Skvalen-syntetase inhibitorer |
Country Status (26)
Country | Link |
---|---|
US (1) | US5770594A (bg) |
JP (1) | JPH10500702A (bg) |
KR (1) | KR960022510A (bg) |
CN (1) | CN1133287A (bg) |
AU (1) | AU4067795A (bg) |
BG (1) | BG100248A (bg) |
BR (1) | BR9505995A (bg) |
CA (1) | CA2207772A1 (bg) |
CZ (1) | CZ344795A3 (bg) |
FI (1) | FI972696A0 (bg) |
GT (1) | GT199500058A (bg) |
HU (1) | HUT74672A (bg) |
IL (1) | IL116399A0 (bg) |
IS (1) | IS4312A (bg) |
LV (1) | LV11325B (bg) |
MA (1) | MA23746A1 (bg) |
MX (1) | MX9704683A (bg) |
NO (1) | NO955288L (bg) |
OA (1) | OA10204A (bg) |
PE (1) | PE60096A1 (bg) |
PL (1) | PL311997A1 (bg) |
SI (1) | SI9500393A (bg) |
SK (1) | SK158795A3 (bg) |
TN (1) | TNSN95133A1 (bg) |
TR (1) | TR199501644A2 (bg) |
WO (1) | WO1996020184A1 (bg) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997048701A1 (en) * | 1996-06-20 | 1997-12-24 | Pfizer Inc. | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors |
US5965553A (en) * | 1996-06-20 | 1999-10-12 | Pfizer Inc. | Squalene synthetase inhibitors |
DE19716120A1 (de) * | 1997-04-17 | 1998-10-22 | Europ Lab Molekularbiolog | Verwendung von cholesterinsenkenden Mitteln |
US8679534B2 (en) * | 1997-12-12 | 2014-03-25 | Andrx Labs, Llc | HMG-CoA reductase inhibitor extended release formulation |
US6403576B1 (en) * | 1998-08-24 | 2002-06-11 | The United States Of America As Represented By The Secretary Of The Navy | Antifungal and antiparasitic compounds |
US20020054871A1 (en) * | 1999-04-12 | 2002-05-09 | Yadong Huang | Methods and compositions for use in the treatment of hyperlipidemia |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
NZ518822A (en) * | 1999-11-04 | 2004-12-24 | Andrx Corp | Treating a mammal with an APP processing disorder such as Alzheimer's Disease and Down's Syndrome by administering at least one HMG-CoA reductase inhibitor |
ES2328225T3 (es) | 2000-11-21 | 2009-11-11 | Janssen Pharmaceutica Nv | Derivados benzoheterociclicos inhibidores de la farnesil-transferasa. |
WO2008121602A1 (en) * | 2007-03-29 | 2008-10-09 | Smithkline Beecham Corporation | Chemical compounds |
GB0803747D0 (en) * | 2008-02-29 | 2008-04-09 | Martin | Enzyme and receptor modulation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG48855A1 (en) * | 1992-04-20 | 1998-05-18 | Takeda Chemical Industries Ltd | 4,1-benzoxazepin derivatives and their use |
AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
MX9702175A (es) * | 1994-09-20 | 1997-06-28 | Pfizer | Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol. |
-
1995
- 1995-06-02 BR BR9505995A patent/BR9505995A/pt not_active Application Discontinuation
- 1995-06-02 SK SK1587-95A patent/SK158795A3/sk unknown
- 1995-06-02 US US08/860,155 patent/US5770594A/en not_active Expired - Fee Related
- 1995-06-02 MX MX9704683A patent/MX9704683A/es not_active IP Right Cessation
- 1995-06-02 JP JP8520314A patent/JPH10500702A/ja active Pending
- 1995-06-02 WO PCT/IB1995/000424 patent/WO1996020184A1/en active Application Filing
- 1995-06-02 CA CA002207772A patent/CA2207772A1/en not_active Abandoned
- 1995-12-13 GT GT199500058A patent/GT199500058A/es unknown
- 1995-12-14 IL IL11639995A patent/IL116399A0/xx unknown
- 1995-12-18 MA MA24097A patent/MA23746A1/fr unknown
- 1995-12-18 PE PE1995287390A patent/PE60096A1/es not_active Application Discontinuation
- 1995-12-19 IS IS4312A patent/IS4312A/is unknown
- 1995-12-21 TN TNTNSN95133A patent/TNSN95133A1/fr unknown
- 1995-12-21 LV LVP-95-379A patent/LV11325B/en unknown
- 1995-12-21 PL PL95311997A patent/PL311997A1/xx unknown
- 1995-12-21 BG BG100248A patent/BG100248A/bg unknown
- 1995-12-22 CZ CZ953447A patent/CZ344795A3/cs unknown
- 1995-12-22 KR KR1019950054933A patent/KR960022510A/ko not_active Application Discontinuation
- 1995-12-22 OA OA60759A patent/OA10204A/en unknown
- 1995-12-22 SI SI9500393A patent/SI9500393A/sl unknown
- 1995-12-22 TR TR95/01644A patent/TR199501644A2/xx unknown
- 1995-12-22 CN CN95120143A patent/CN1133287A/zh active Pending
- 1995-12-22 HU HU9503783A patent/HUT74672A/hu unknown
- 1995-12-22 NO NO955288A patent/NO955288L/no unknown
- 1995-12-22 AU AU40677/95A patent/AU4067795A/en not_active Abandoned
-
1997
- 1997-06-23 FI FI972696A patent/FI972696A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996020184A1 (en) | 1996-07-04 |
IS4312A (is) | 1996-06-24 |
CA2207772A1 (en) | 1996-07-04 |
PE60096A1 (es) | 1996-12-28 |
KR960022510A (ko) | 1996-07-18 |
NO955288D0 (no) | 1995-12-22 |
BG100248A (bg) | 1996-07-31 |
FI972696A (fi) | 1997-06-23 |
SI9500393A (en) | 1997-04-30 |
US5770594A (en) | 1998-06-23 |
FI972696A0 (fi) | 1997-06-23 |
MA23746A1 (fr) | 1996-07-01 |
SK158795A3 (en) | 1997-01-08 |
IL116399A0 (en) | 1996-03-31 |
LV11325A (lv) | 1996-06-20 |
TNSN95133A1 (fr) | 1996-02-06 |
CN1133287A (zh) | 1996-10-16 |
MX9704683A (es) | 1997-09-30 |
LV11325B (en) | 1997-02-20 |
PL311997A1 (en) | 1996-06-24 |
CZ344795A3 (en) | 1996-09-11 |
HU9503783D0 (en) | 1996-04-29 |
TR199501644A2 (tr) | 1996-11-21 |
JPH10500702A (ja) | 1998-01-20 |
GT199500058A (es) | 1997-06-05 |
HUT74672A (en) | 1997-01-28 |
AU4067795A (en) | 1996-07-04 |
BR9505995A (pt) | 1997-12-23 |
OA10204A (en) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
DE69424517D1 (de) | Gaserzeugende Zusammensetzungen | |
NO992512D0 (no) | Aminoguanidiner og alkoksyguanidiner som proteaseinhibitorer | |
MX9800625A (es) | Marcfortinas y paraherquamidas antiparasitarias. | |
DE69116550D1 (de) | Steroid-sulfatase-inhibitoren | |
MY113489A (en) | Reversible protease inhibitors | |
DE69729881D1 (de) | Azidfreie gaserzeugende zusammensetzungen | |
JO2410B1 (en) | 6. Replaced pyrido-pyrimidines | |
DE69402043D1 (de) | Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen | |
TR199701074T1 (xx) | Sinerjistik bile�imler. | |
DE69840603D1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
DK0840606T3 (da) | Små di- og trivalente molekyler som selectininhibitorer | |
DK0700380T3 (da) | N-Alkylthiopolyaminderivater som radioprotektive midler | |
HK1049796B (zh) | 包括某一基因的抑制劑或阻遏物以及與該基因的表達產物相結合的分子的混合物 | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
ATE238343T1 (de) | Inhibitoren des endothelin konvertierenden enzyms | |
NO955288L (no) | Skvalen-syntetase inhibitorer | |
DE19581542T1 (de) | Gaserzeugende Zusammensetzung | |
NO981019L (no) | Deodoriserende preparater inneholdende kationiske biopolymerer, aluminiumklorhydrat og esteraseinhibitorer | |
NO954321D0 (no) | 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer | |
GB2324091A (en) | Metalloproteinase inhibitors | |
MXPA02007173A (es) | Compuestos calciliticos. | |
DE69831737D1 (de) | Neurotrypsin | |
EP1383511A4 (en) | CALCILYTIC COMPOUNDS |